152 related articles for article (PubMed ID: 30746222)
1. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.
Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R
J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222
[TBL] [Abstract][Full Text] [Related]
2. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
Front Oncol; 2022; 12():946800. PubMed ID: 36081555
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
[TBL] [Abstract][Full Text] [Related]
4. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
5. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
Front Oncol; 2021; 11():726811. PubMed ID: 34956862
[TBL] [Abstract][Full Text] [Related]
6. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
7. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study.
Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q
Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145
[TBL] [Abstract][Full Text] [Related]
8. Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis.
Chen C; Ni Q; Shi Y; Fu S; Pan X; Wang Y; Yang J; Wang R
Transl Cancer Res; 2019 Apr; 8(2):574-582. PubMed ID: 35116790
[TBL] [Abstract][Full Text] [Related]
9. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
[TBL] [Abstract][Full Text] [Related]
10. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
11. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
12. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.
Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J
J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526
[TBL] [Abstract][Full Text] [Related]
14. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
[TBL] [Abstract][Full Text] [Related]
15. Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic.
Wang L; Jiao F; Dong L; Li Q; Liu G; Hu X
Front Surg; 2021; 8():685186. PubMed ID: 34291078
[No Abstract] [Full Text] [Related]
16. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
[TBL] [Abstract][Full Text] [Related]
17. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
Front Oncol; 2020; 10():661. PubMed ID: 32500023
[No Abstract] [Full Text] [Related]
18. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
Front Oncol; 2021; 11():610638. PubMed ID: 34026604
[TBL] [Abstract][Full Text] [Related]
19. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
[TBL] [Abstract][Full Text] [Related]
20. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
